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a  b  s  t  r  a  c  t
The authors present the case of a patient with a giant cell tumor of the left femoral neck,
with  adjacent progressive invasion of bone tissue. Initial treatment was done with local
curettage and autologous bone graft from ﬁbula, electrocauterization and ﬁlling with methyl
methacrylate. A local tumoral relapse was present after one year; therefore a new surgical
procedure was necessary, with proximal femoral wide resection and unconventional endo-
prosthesis ﬁxation. The article discusses the clinical aspects and surgical treatment. This
report aimed to demonstrate the necessity to perform wide resection for giant cell tumor
of  the femoral neck, prioritizing total resection of the tumor and its local extension, preser-
ving limb integrity and demonstrating the complete failure of preserving surgery in cases
of  femoral neck involvement.
©  2016 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora
Ltda. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Os autores apresentam um caso de uma paciente portadora de tumor de células gigantes do
colo  do fêmur esquerdo com invasão progressiva de tecido ósseo adjacente. Foi tratado ini-
cialmente com esvaziamento por meio de curetagem local e enxertia autóloga com tabiques
da  fíbula, eletrofulgurac¸ão e preenchimento com metilmetacrilato. A paciente evoluiu com
umores de células gigantes recidiva da lesão tumoral local após um ano, foi necessária uma  nova intervenc¸ão cirúr-
gica,  com ressecc¸ão em bloco da parte proximal do fêmur e ﬁxac¸ão de endoprótese não
convencional. São discutidos os aspectos clínicos e a abordagem terapêutica. O relato tem
por  func¸ão demonstrar a necessidade de abordar o tumor de células gigantes do colo do
fêmur, em obediência aos princípios oncológicos de ressecc¸ão óssea, com prioridade para
 Study conducted at the Hospital Geral de Goiânia, Servic¸o de Cirurgia do Quadril, Goiânia, GO, Brazil.
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a total exérese do tumor e sua extensão local, preservac¸ão da integridade do membro e
demonstrac¸ão  da total falha de tentativas preservadoras no caso de acometimento do colo
femoral.
©  2016 Sociedade Brasileira de Ortopedia e Traumatologia. Publicado por Elsevier
Editora Ltda. Este e´ um artigo Open Access sob uma licenc¸a CC BY-NC-ND (http://Introduction
Giant cell tumor (GCT) is deﬁned as an aggressive benign bone
tumor with uncertain biological behavior, characterized histo-
logically by richly vascularized tissue with ovoid and fusiform
cells and numerous osteoclastic giant cells, evenly distributed
throughout the tumor tissue.1,2
GCT mainly affects young adults between the ages of 20–35
years, and the most frequent locations are the distal femur and
proximal tibia. It is more  common in females, and constitutes
8% of primary bone tumors.3
The main purpose of this report is to demonstrate the
importance of resection following oncological principles for
such lesions with involvement the femoral neck and whose
treatment is mainly surgical, with radical replacement of the
segment; in case of failure of other techniques, such as curet-
tage and autologous or homologous bone grafts, prosthetic
replacement (non-conventional endoprosthesis) is manda-
tory.
Case  report
Female patient, aged 33 years, reported pain in the left hip
and lower back for the last six months and had no history
of trauma or physical effort and progressive worsening of the
pain. At physical examination, the patient presented pain on
palpation in the anterior aspect and during movement  of the
left hip, with normal range of motion.
The initial radiological study (pelvis radiograph) disclosed
the presence of an extensive osteolytic lesion on the femoral
neck and proximal third of the greater trochanter (Fig. 1).
Magnetic resonance imaging (MRI) revealed an expan-
sile, destructive, insufﬂated bone lesion the epiphysis-
metaphyseal region of the left proximal femur, with regular
and well-deﬁned contours, which started on the femoral neck
and extended to the anterior aspect of the femoral head. The
lesion presented a homogeneous solid matrix, hypointense
on T1, and with intermediate signal on T2, with intense
uptake after intravenous contrast administration. Bone mar-
row edema was observed near the lesion, without signs of
expansion to the adjacent soft tissue (Fig. 2).
In light of these ﬁndings, the possibility of GCT was con-
sidered and a bone biopsy was proposed; the biopsy was
performed immediately, corroborating the primary diagnostic
hypothesis. The authors decided to perform an intralesional
resection, with local curettage and electrocauterization as
an adjuvant treatment, as well as ﬁlling of the cavity with
autologous bone graft from the ﬁbula and bone cement
(methylmethacrylate) (Fig. 3).creativecommons.org/licenses/by-nc-nd/4.0/).
The patient had no signiﬁcant clinical abnormalities. Full
weight bearing was authorized after 120 days. One year after
surgery, a control MRI was performed; although the patient
is completely asymptomatic, nodular lesions of regular and
well-deﬁned borders were observed, with T1 and T2 isoin-
tensity, homogeneously capturing the intravenous contrast in
the intertrochanteric region, in the lower portion of the sur-
gical cavity. Bone marrow edema was observed adjacent to
the lesion and to the bone graft/cement, as well as reactive
periostitis, consistent with tumor recurrence (Fig. 4).
In light of these ﬁndings, a new surgical intervention was
proposed; a block resection of the proximal third of the femur
was performed, replaced with non-conventional modular tita-
nium endoprosthesis and uncemented acetabular prosthesis
(Figs. 5 and 6).
Discussion
The treatment of GCT is essentially surgical. There is evidence
contrary to curettage, but there is a correlation with surgery
and method, histologic type, tumor size, location, and age
of the patient – these are factors that directly inﬂuence the
prognosis, as well as lesion staging.4
In 1983, Enneking proposed a three-stage radiographic clas-
siﬁcation: stage I – tumor with well-deﬁned edges and cortical
integrity; stage II – expanded cortex with well-deﬁned edges;
stage III – non-deﬁned edges with soft tissue invasion. Stage I
is treated with curettage and adjuvant treatment (electrocau-
terization, methylmethacrylate, liquid nitrogen, and phenol).
Stage II can also be treated by this method, but it presents
worse functional outcomes when treated similarly to stage III
(wide resection of the lesion and replacement).4–6
Bone cement has no biological properties and long-term
results are very difﬁcult to anticipate, especially when this
method is used in the treatment of GCT.7,8 Although some
authors have demonstrated excellent results with this method
based on the clinical approach, no deleterious effects were
directly related to the use of methylmethacrylate and other
adjuvant treatments that have been recommended to reduce
GCT recurrence were observed.9
Treatments involving substitution, such as reconstruction
of the proximal femur with femoral prostheses, the use of
proximal endoprosthesis for large replacements of proximal
femoral neoplasms, modular titanium endoprosthesis, and
conventional total hip arthroplasty are techniques used for
GCT of the hip.10–13Resection of the proximal third of the femur is deﬁned
as a surgery that removes the previously deﬁned region of
bone damage caused by GCT and the macroscopically affected
local tissues. The proximal block of the femur is completely
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Fig. 1 – Hip radiograph in anteroposterior (A) and Lowenstein lateral (B) views showing osteolytic lesion in the left femoral
neck.
Fig. 2 – Magnetic resonance imaging of the pelvis, coronal in T2 (A), and axial plane with contrast in T2 (B) showing lesion
in the left femoral neck.
Fig. 3 – Hip radiograph in anteroposterior (A) and Lowenstein lateral (B) views showing postoperative GCT in the left femoral
neck.
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Fig. 4 – Magnetic resonance imaging of the left hip in sagittal plane in T2, showing GCT recurrence one year after the ﬁrst
surgery.
Fig. 5 – Intraoperative images with endoprosthesis.
Fig. 6 – Left hip radiographs in anteroposterior view, showing the section with safety margin (A), and the endoprosthesis
for the proximal femur (B and C).
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emoved and a cementless prosthesis is used in acetabular
reparation to ensure the durability and reliability of the sys-
em.
Resection of the proximal third of the femur is a suitable
urgical treatment for cases of femoral neck GCT. As in the
resent case, it is a viable surgical alternative to resection with
urettage and other ﬁlling methods, which have been proven
o be comparatively ineffective.
onclusion
he femoral neck is not the most common region for the
resence of GCT. In the present case, the authors con-
luded that the femoral neck GCT should be widely resected,
ursuant to all the criteria and principles of oncological
urgery. Block resection of the entire lesion with a safety mar-
in for the removal of the entire affected area, as well as
he underlying tissue that presented contaminated macro-
copic features, followed by a non-conventional prosthetic
eplacement was opted. The authors emphasize the need
or complete and safe resection to prevent recurrence of the
esion.
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